about
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulumA Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome-Review of the Literature.Eosinophilic hepatic necrosis in hypereosinophilic syndrome.Long-lived intestinal tuft cells serve as colon cancer-initiating cells.Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis.Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis.Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinomaBRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreasExploration of Deregulated Long Non-Coding RNAs in Association with Hepatocarcinogenesis and Survival.Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.Obesity and microvascular invasion in hepatocellular carcinoma.Depth of resection using two different endoscopic mucosal resection techniques.Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.Management of Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy in a Patient with Scleroderma: Case Report and Review of the Literature.HER2 Heterogeneity in Gastroesophageal Cancer Detected by Testing Biopsy and Resection Specimens.Can diffusion-weighted imaging serve as a biomarker of fibrosis in pancreatic adenocarcinoma?Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivoDclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis.Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver.HepPar-1 and Arginase-1 Immunohistochemistry in Adenocarcinoma of the Small Intestine and Ampullary Region.Rare pancreatic tumors.β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.Esophagitis dissecans superficialis.Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients.Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice.Crypt apoptotic body counts in normal ileal biopsies overlap with graft-versus-host disease and acute cellular rejection of small bowel allografts.Identification of recurrent mutational events in anorectal melanoma.Insulin-like growth factor binding protein-3 inhibits colitis-induced carcinogenesis.Anorectal gastrointestinal stromal tumors: CT and MR imaging features with clinical and pathologic correlation.
P50
Q28509611-E9D2F7F7-C35A-418A-8315-C31FACBB5CE4Q33770113-3F549D5B-0AED-4C35-806F-872AC92AD586Q34113045-8D8B653B-F58D-4279-88E2-8438D35B0833Q34401562-B9898071-8374-47A1-9C46-42EA2F9FB966Q35227134-A20AC52C-22F4-486B-B8CC-F4AF6889E1DCQ35585043-8D971060-32E1-4CB1-8E32-9D74AA2743F4Q35631309-4B8C8C9C-59B4-4CDD-AF20-EC2EE0B8EF10Q35783104-48A2A5B4-75E9-439D-B926-A7F226214127Q36102884-BC76071C-EB4A-4E79-823B-2C4B13B693ECQ36567393-281DCE5D-7885-46F3-827C-EA8152E042D8Q36668087-07CB0787-AE31-4E5B-91A3-4B4B23A9B52CQ36708746-7872134F-AAA8-4914-AFF0-1C1222A67CF6Q36708755-0AA990C0-8B59-45E0-BDCD-4EC6216E22A9Q37015609-B26723C5-1912-4776-A73C-B5BB5EF65B88Q37529593-5B50A1BD-7053-4C7C-A5B8-3D92A375FAB8Q37558614-88C82596-23DA-488D-AC6B-947B64E926D5Q37558621-9833EE36-E051-4371-9CA9-3312F606FF84Q37558625-52CBF22A-854D-4735-9ED9-5ECFFA7F5087Q37558631-8321230C-02D6-486D-AB40-124F096108BCQ37659419-23481B7B-0240-4D1F-AB0F-7CAF42D22B61Q38010098-4CC2CE67-A0C9-4FC7-84E9-B9DB2955C5F5Q38637319-FE43EE21-39C5-4BBB-8FAB-197389842FDFQ39115648-C49397C9-57F1-4378-B609-6183853F1BECQ39437873-C9C82236-5EBE-4D3B-B07F-D4A9428C6D01Q40003054-593BC0BE-6416-4337-955B-DF239ED8B19EQ40130242-9F9D3E95-64A3-4927-9410-B24C696FE8A5Q41175540-807C4F00-9A6E-4960-B972-4DF89620E922Q43796958-7FEDDB9C-8CE6-4FD5-812E-480CBA2AA92BQ43858642-3445D1F3-8876-4572-AD30-0BDE71B7667AQ44839856-72DF83FD-2A10-4A1B-9A50-E712E7DD46E7Q46496985-E2CF0228-1EFD-4182-A008-51A2B2955157Q47816496-7CD6576B-B042-4797-8920-C6ED3D1C435BQ47911126-C2FDF284-8AC8-4D03-8130-B6C9B21B2445Q50521228-0C3142EB-EC24-4678-B6BE-1C5EA7BBB4F9Q52588190-2EAD5851-27D7-4D6F-92DD-BACAC2B93709Q52661910-53F74F4B-8ADB-475A-A6A4-0305F85ABAD4Q52866473-973A1612-08C3-4592-88A2-00BE35C47139Q53009744-85243F47-6E0A-4A92-8D82-807F46F84DFBQ53536951-92C8F055-5786-404D-88A7-F3BDB9F7747CQ53651906-A077AC01-F289-45ED-B359-280F9DBB356B
P50
description
researcher
@en
wetenschapper
@nl
name
H Remotti
@en
H Remotti
@nl
type
label
H Remotti
@en
H Remotti
@nl
prefLabel
H Remotti
@en
H Remotti
@nl
P106
P31
P496
0000-0003-1555-9299